When new drug discoveries warrant scientific investigation, but require academic-like research and 3D assay development not available in-house, partner with Likarda. We apply our world-class, proven tools and processes to pharma research projects for faster and more predictable results.
Scalability Brings Opportunity to Go from Bench to Bedside Faster and Confidently
No pharmaceutical company can do everything when it comes to scaling to meet the financial investment or timing associated with early, new drug research and development. This can cause promising drugs or therapies to be turned away because they aren’t the right fit for the company. That leads to lost business and revenue, as well as potentially life-changing discoveries left undiscovered.
Likarda provides outsourced, early phase drug discovery research for pharmaceutical companies across the U.S. and around the world, discovering promising drugs and advancing them to the next research phase. Our research team performs academic-level work, yet we tailor time, price and scalability to the pharmaceutical market. Then we return our early phase findings back to the pharmaceutical company so that decisions can be made to move forward or not. That’s how business loss becomes business opportunity
